Cannabis Can Cure Depression

See also: Marijuana for depression and bipolar disorder

Reprinting an interesting comment from 2010, found posted to Cannabinoids: every body loves them, some bodies need them

“…This is a wonderful article and I ran across it because I was looking for theories regarding endocannabinoid deficiencies.

I have battled clinical depression, which at times has been totally debilitating, for about 16 years now (12 of which I have been on pharmaceutical medication). I was advised early on to stay away from drugs and alcohol to try to stay mentally stable and of course I lumped marijuana into that category.

I have tried countless pharmaceutical anti-depressants over the past 12 years; some of them made me feel like a zombie, some of them had terrible side effects, and some of them were just completely ineffective. I finally found one that worked “best”—and by “best” I mean it was the most tolerable and most effective of the ones I’d tried. I continued to be mildly to moderately depressed on this medication, but again, this was the “best” one I had encountered in 12 years.

A year and a half ago I started looking into alternative treatments because I was unhappy with the side-effects of the anti-depressant I was taking (hand tremors, headaches, insomnia). I was also hoping I could find something that would be more effective for treating my depression. I had been hearing a lot about medical marijuana so I decided to do some research into whether or not that could be used to treat depression, even though I was convinced that marijuana was “bad” for my mental health.

I spent weeks researching cannabis, its potential risks and benefits, the mechanism through which it interacts with the brain, etc. I finally came to the conclusion that most of what I had learned about cannabis was a complete lie (it kills brain cells, it causes cancer, it compromises your immune system, etc.) and I also realized that the risks and side-effects of any of the countless anti-depressants I had tried over the years were FAR more significant than with cannabis.

I started using cannabis on a daily basis, ONCE a day before I went to bed, and within a short period of time I felt like my old self again, for the first time in over a decade. After about 6 months of nightly cannabis use I decided that I would stop taking my pharmaceutical anti-depressant. I tapered myself off that drug—and was finally free of the associated hand tremors, headaches, and insomnia—and then continued to use cannabis once a day. I had no problems with depression, whatsoever.

Recently I experimented with ceasing my cannabis use to find out whether or not it was really acting as an antidepressant or whether I had just stopped having problems with depression and had mistakenly attributed that to the cannabis. I felt fine for about 2 weeks after I stopped my nightly use of cannabis. During the third week, though, I started to feel depressed, and by the fourth week I was having days were I was VERY depressed, crying for no reason, feelings of worthlessness, etc. I then decided that the cannabis MUST have been working as my anti-depressant after all, so I went back to using it once a day before bedtime.

Within 2 days I felt COMPLETELY better again—that is, I went from a moderate depression to feeling no depression whatsoever. I have NEVER had that fast of a response with any pharmaceutical drug I have tried in the past; those have all taken weeks to have any effect (if they had an effect at all), and even then the effect was not enough to rid me of my depression completely.

Thanks to cannabis I feel like I have my life back. Please understand I am just a person with chronic depression that was never relieved by pharmaceutical drugs and I am NOT encouraging anyone else with mental health problems to follow this advice. HOWEVER, there is absolutely NO DOUBT in my mind, after all my experience with pharmaceutical drugs and more recently cannabis, that MY depression is somehow linked to an endocannabinoid deficiency.

I feel like 17 years of my life were stolen from me by a system that considers cannabis a “street drug” and therefore forces people with depression caused by endocannabinoid deficiencies into a system where they are treated with dangerous and ineffective pharmaceutical drugs. Please understand, I am not saying that these pharmaceutical drugs are ineffective in ALL cases, but in my personal case they were NOT very effective and I never ended up “feeling like myself again” the way I do when I use cannabis instead.

I hope that one day scientists and doctors can freely study the theory of endocannabinoid deficiency without the government and bureaucrats standing in the way. I also hope that people who want to supplement cannabinoids when their body doesn’t produce enough can use the natural plant form instead of being bullied into using the less-effective, more expensive pharmaceutical versions of cannabinoid-based drugs.

Kaneh Bosm: The Hidden Story of Cannabis in the Old Testament

Now backed by archeological evidence:

Cannabis and Frankincense at the Judahite Shrine of Arad 28 May 2020

Two limestone monoliths, interpreted as altars, were found in the Judahite shrine at Tel Arad. Unidentified dark material preserved on their upper surfaces was submitted for organic residue analysis at two unrelated laboratories that used similar established extraction methods. On the smaller altar, residues of cannabinoids such as Δ9-teterahydrocannabinol (THC), cannabidiol (CBD) and cannabinol (CBN) were detected, along with an assortment of terpenes and terpenoids, suggesting that cannabis inflorescences had been burnt on it. Organic residues attributed to animal dung were also found, suggesting that the cannabis resin had been mixed with dung to enable mild heating. The larger altar contained an assemblage of indicative triterpenes such as boswellic acid and norursatriene, which derives from frankincense. The additional presence of animal fat―in related compounds such as testosterone, androstene and cholesterol―suggests that resin was mixed with it to facilitate evaporation. These well-preserved residues shed new light on the use of 8th century Arad altars and on incense offerings in Judah during the Iron Age.

Interview with renowned Cannabis researcher Melanie Dreher

Listen to the half hour interview here

CENTURY OF LIES

APRIL 24, 2019

DEAN BECKER: The failure of drug war is glaringly obvious to judges, cops, wardens, prosecutors, and millions more now calling for decriminalization, legalization, the end of prohibition. Let us investigate the Century Of Lies.

DOUG MCVAY: Hello, and welcome to Century of Lies. I’m your host Doug McVay, editor of DrugWarFacts.org.

Well, this week we’re going to hear an interview with Melanie Dreher, PhD. She’s also a registered nurse and a Fellow of the American Academy of Nursing. It was such an honor to have the chance to sit down with her and to get this interview, and I hope you folks enjoy it. Before any ado can possibly be furthered, let’s get to it.

Could you tell me who you are and what you do?

MELANIE DREHER, PHD, RN, FAAN: Melanie Dreher, and I am Dean Emeritus at Rush University, and I’m a cannabis researcher, four decades of cannabis research.

DOUG MCVAY: Doctor Dreher, there is so very much that I could be asking you about, and in so little time. Just, well, what inspired you? This is probably a big question, too, but I’ll do it. What inspired you to make cannabis, I mean, I don’t know if saying making cannabis your career is the right way to say it. What inspired your interest in this plant?

MELANIE DREHER, PHD, RN, FAAN: Oh, it was purely by accident. I was a graduate student at Columbia University. My professor decided to send me to Jamaica to do an ethnographic study and recruit subjects for a medical study.

And it was 1969. It was when Neal Armstrong first set foot on the moon, and 400,000 of my best friends were in Woodstock, which is where I really wanted to be. And, I ended up on a mountaintop, having no experience with cannabis, never having been to Jamaica, and not knowing how to do ethnography. So I was perfectly qualified for a career as an ethnographer in cannabis research.

And that was the beginning. And, from there, we — my first study there was really looking at the amotivational syndrome, which was a very popular concept in the early Seventies, suggesting that cannabis use made people lose their interest in productive activities, drop out, drop out of college, not being able to finish simple tasks, et cetera.

And the reason I selected that as my doctoral dissertation was because I had just spent the summer before in Jamaica where men and women were using cannabis to help them work harder.

So, something was going on here, and it warranted a cross-cultural study. So I ended up doing a study of rural farmers, and sugar cane workers, and the nice thing about studying sugar cane workers is that their productivity is measured in the tons that they cut, because that’s how they get paid.

And, after a year of — I’m sorry, yes, actually two years working with cane cutters and measuring their productivity, and getting to know them as people in a certain context, I discovered that actually there was no difference in their productivity. So whether they smoked cannabis or whether they didn’t, men were working hard.

But if they believed that cannabis was helping them work harder, that was a good thing.

So, while I was there, I also discovered that women were preparers of cannabis tea and medicines that they would give to their families and children, in many ways, to help the children work harder. They made sure that children had a cannabis tea before they went to school, and especially if they were taking a test, they wanted their children to be able to concentrate. And they did that by preparing them tea.

So I did a tiny study that was then published in an education journal on whether the children who had cannabis tea performed better academically than children who didn’t have the tea. And, the result that, and I’m not — wasn’t sure we’d get this result, but in fact, the children who performed better in school were the tea drinkers.

And, I think, one of the good things about doing this ethnographic work is that you come out of the laboratory and study natural behavior in its natural context, and understand why cannabis was working in this instance.

And certainly the mothers and fathers who cared enough to make sure that their children would partake of their, you know, limited, little store of cannabis, were also the mothers and fathers who made sure their children had clean uniforms to wear, and pencils, and notebooks to go to school with, and that they were actually attending school more often.

So it was, cannabis tea was part of a complex of good parenting. Interestingly, we asked the teachers ahead of time which children, they did not know whether the children were getting tea or not. We asked them which children they thought would be getting the tea.

And of course, the teachers were representing middle class, they disapproved of giving cannabis tea to children, and got it completely wrong. The children that they thought were the high performers were indeed the high performers, but they were not the children that they thought were drinking tea.

So, it was an interesting little study that then led on to working with mothers, and a few women had actually begun smoking, which was out of sort of the cultural order of Jamaica.

And at that time, the United States was still reeling from the thalidomide event, and were very interested in the substances, the teratogenic factors of all substances that women were using during pregnancy.

So I was able to get the March of Dimes to fund a small study, looking at the — at the effects, the neonatal and perinatal effects of cannabis exposure during pregnancy. And we used thirty cannabis using women and thirty non, and they were matched for age and parity, and socioeconomic status.

And that study also engaged the Brazelton Neonatal team from Harvard, and they helped administer that schedule, to look at children’s neurological and behavioral — babies, neonates, neurological and behavioral performance.

And counterintuitively, one day, the children — babies, in both groups, were non-differentiated. I mean, we didn’t — we could not find anything that would distinguish the exposed babies from the non-exposed babies on the Brazelton Scale.

At one month, the exposed children performed significantly better on every variable of the Brazelton Scale. And we were very surprised. We didn’t think we’d ever get anyone to publish it. In fact, Pediatrics did publish it a little bit later, in 1995, and interestingly, we got no pushback at all. I thought there would be letters coming in, how can you say this doesn’t make a difference. It was totally silent.

It was not until 20 years later that all of a sudden this became an important study. But in the meantime, pregnant women who use marijuana found this study, and they used this study, and it got, you know, circulated among other pregnant women. So it did have an enormous impact.

Frankly, that little study is probably — made us rockstars among cannabis users today and advocates of cannabis. It was very well conducted, we worked hard, we got it right.

And once again, by looking at this behavior in context, as opposed to the laboratory, we could see that differences between the two samples that had nothing to do with age or parity or socioeconomic status, but really how they functioned economically, where most of the smoking mothers, or the using mothers, were not in conjugal unions. They were self-supporting.

Listen to the entire interview here